CTLA4 and neoplasm: These results demonstrate that the potentiation effect of PIC on the in situ vaccination of RT can be applied in diverse tumor settings and can prime a potent systemic anti-tumor immune response when combined with anti-CTLA-4 for the treatment of metastatic disease.